Point72 Asset Management’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,206,893
Closed -$3.6M 2380
2023
Q4
$3.6M Buy
2,206,893
+125,600
+6% +$215K 0.01% 1027
2023
Q3
$6.2M Buy
2,081,293
+168,535
+9% +$642K 0.02% 819
2023
Q2
$8.53M Buy
+1,912,758
New +$8.56M 0.03% 638
2020
Q2
Sell
-106,805
Closed -$408K 897
2020
Q1
$408K Buy
+106,805
New +$396K ﹤0.01% 677
2019
Q2
Sell
-161,913
Closed -$6.12M 1424
2019
Q1
$6.12M Buy
161,913
+109,190
+207% +$4.07M 0.03% 518
2018
Q4
$1.92M Buy
+52,723
New +$1.62M 0.01% 725

Other funds holding IFRX

Point72 Asset Management's IFRX Position: Q1 2024 in Review

Point72 Asset Management sold out of InflaRx (IFRX) in Q1 2024, closing a stake of 2,206,893 shares — an estimated $3.6M sold.

Point72 Asset Management first reported a position in IFRX in Q4 2018 and held it in 6 quarters. The position peaked at $8.53M in Q2 2023. 37 funds tracked by Wall St. Rank hold IFRX as of Q1 2024.

  • Point72 Asset Management reported no remaining InflaRx position as of Q1 2024 after selling out during the quarter.
  • Point72 Asset Management sold 2,206,893 InflaRx shares in Q1 2024, an estimated $3.6M.
  • Point72 Asset Management first reported a position in InflaRx in Q4 2018 and held it in 6 quarters.
  • Point72 Asset Management's InflaRx position peaked at $8.53M in Q2 2023.
  • 37 funds tracked by Wall St. Rank held InflaRx as of Q1 2024.

Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.